Leaderboards/Vascular Malformations Diagnosis and Treatment

Vascular Malformations Diagnosis and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Yoonho Kim
Massachusetts Institute of Technology
2
Aileen A. Ren
University of Pennsylvania
3
Abel Clemens Adriaan Sandmann
Amsterdam Neuroscience
4
Prasert Iampreechakul
Neurological Institute of Thailand
5
Lola Zerbib
Hôpital Necker-Enfants Malades
6
Antoine Fraissenon
Inserm
7
Jiancong Weng
China-Japan Friendship Hospital
8
Hyeongseop Keum
Korea Advanced Institute of Science and Technology
9
Elijah Almanzor
University of Cambridge
10
Mohammadhassan Ansarizadeh
University of Oulu

Papers

1
Sotorasib for Vascular Malformations Associated with <i>KRAS</i> G12C Mutation
New England Journal of Medicine|2024
34 cit.
2
Publication in Signal Transduction and Targeted Therapy (2024) [25 citations, W4399711928]
Signal Transduction and Targeted Therapy|2024
25 cit.
3
Publication in Advanced Materials (2024) [18 citations, W4391485170]
Advanced Materials|2024
18 cit.
4
Publication in European Stroke Journal (2024) [11 citations, W4394834078]
European Stroke Journal|2024
11 cit.
5
Publication in Bioinspiration & Biomimetics (2024) [8 citations, W4399067991]
Bioinspiration & Biomimetics|2024
8 cit.
6
Publication in Journal of Neurology (2024) [8 citations, W4405323404]
Journal of Neurology|2024
8 cit.
7
Disseminated and migratory sparganosis in the central nervous system: A case report and literature review of combined spinal and intracranial involvement
Surgical Neurology International|2025
7 cit.
8
Dural arteriovenous fistula involving superior petrosal sinus with petrosal venous drainage in association with cerebral venous thrombosis: Literature review and illustrative case
World Neurosurgery X|2024
6 cit.
9
Long-term surveillance in an infant with spontaneous obliteration of pial arteriovenous malformation and large intranidal aneurysm: A unique case observation
Surgical Neurology International|2024
5 cit.
10
Outcomes and safety of repeated microvascular decompression for recurrent trigeminal neuralgia
Neurosurgical Review|2025
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Joerg-Christian Tonn
LMU Klinikum
2
Philipp Dammann
Essen University Hospital
3
Elisa Boscolo
Cincinnati Children's Hospital Medical Center
4
Paloma Triana
Hospital Universitario La Paz
5
Robert E. Dewhurst
Perron Institute for Neurological and Translational Science
6
Somkiet Siriwimonmas
Bumrungrad International Hospital
7
Ziyuan Guo
Shandong University of Science and Technology
8
L. Frank Huang
First People's Hospital of Nanning
9
Joshua D. Wythe
University of Virginia
10
Eng-King Tan
Wuhan University

Papers

1
Modeling blood-brain barrier formation and cerebral cavernous malformations in human PSC-derived organoids
Cell stem cell|2024
129 cit.
2
EZ Clear for simple, rapid, and robust mouse whole organ clearing
eLife|2022
98 cit.
3
MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ
Nature Communications|2023
30 cit.
4
NRASQ61R mutation in human endothelial cells causes vascular malformations
Angiogenesis|2022
25 cit.
5
Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations
Neurology|2023
25 cit.
6
Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non‐familial disease
European Journal of Neurology|2022
22 cit.
7
Quality of life and mood assessment in conservatively treated cavernous malformation‐related epilepsy
Brain and Behavior|2022
20 cit.
8
Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance
Scientific Reports|2022
16 cit.
9
Natural course of cerebral and spinal cavernous malformations: a complete ten-year follow-up study
Scientific Reports|2023
15 cit.
10
Optimization methods rooted in optimal control
Science China Information Sciences|2024
14 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Robert F. Spetzler
Barrow Neurological Institute
2
L. Dade Lunsford
University of Pittsburgh
3
Jason P. Sheehan
University of Virginia
4
Miikka Vikkula
Unknown
5
Issam A. Awad
University of Chicago
6
Neil A. Martin
Unknown
7
Julie Glowacki
Brigham and Women's Hospital
8
Michael T. Lawton
Barrow Neurological Institute
9
Douglas A. Marchuk
Duke University
10
Elisabeth Tournier‐Lasserve
Inserm

Papers

1
Hemangiomas and Vascular Malformations in Infants and Children
Plastic & Reconstructive Surgery|1982
3.3k cit.
2
A proposed grading system for arteriovenous malformations
Journal of neurosurgery|1986
2.5k cit.
3
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Nature|1996
2.1k cit.
4
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
Nature Genetics|1994
1.5k cit.
5
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products
Nucleic Acids Research|1991
1.2k cit.
6
Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2
Nature Genetics|1996
1.1k cit.
7
Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
Cell|1996
809 cit.
8
Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblasts
Aging Cell|2008
797 cit.
9
Normal Perfusion Pressure Breakthrough Theory
Neurosurgery|1978
778 cit.
10
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4)
The Lancet|2004
754 cit.

Reagents for Vascular Malformations Diagnosis and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 70

CD20 (E3N7O) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

#35811$465
View Evidence →
Cell Signaling Technology

Acidic FGF (11H11) Rabbit Monoclonal Antibody

#3139$158,348
View Evidence →
Cell Signaling TechnologyEvidence 66

Moesin Antibody

#3146$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

Akt (pan) (C67E7) Rabbit Monoclonal Antibody (Sepharose Bead Conjugate)

#4343$465
View Evidence →
Cell Signaling TechnologyEvidence 65

ACE2 Antibody

#4355$136,317
View Evidence →
Agilent/Dako

Universal Negative Control for IR-Series Rabbit Primary Antibodies

#IR600
View Evidence →